# Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/epcoritamab-a-novel-subcutaneous-cd3xcd20-bispecific-t-cell-engaging-antibody-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Catherine Thiéblemont,Tycel Phillips,Hervé Ghesquières,Chan Y. Cheah,Michael Roost Clausen,David Cunningham,Young Rok,Tatyana Feldman,Robin Gasiorowski,Wojciech Jurczak,Tae Min Kim,David Lewis,Marjolein van der Poel,Michelle Poon,Mariana Cota Stirner,Nurgul Kilavuz,Christopher Chiu,Menghui Chen,Mariana Sacchi,Brian Elliott,Tahamtan Ahmadi,Martin Hutchings,Pieternella J. Lugtenburg |
| Citations | 550 |
| DOI | 10.1200/jco.22.01725 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.22.01725?role=tab |
| OpenAlex ID | https://openalex.org/W4312115076 |
| PMID | 36548927 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Tae Min Kim](https://scholariq.org/researchers/tae-min-kim/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.